Refresh

0 Hits

Wiese | Diehl | Huster

Disease Interception als Chance und Herausforderung

Eine interdisziplinäre Analyse
Nomos,  2024, 192 Pages

ISBN 978-3-7560-1633-4


Our continuation service: You will receive new series titles or new editions automatically and without obligation to purchase. If you wish to do so, you can mark it in the shopping cart.

The work is part of the series Bochumer Schriften zum Sozial- und Gesundheitsrecht (Volume 26)
59,00 € incl. VAT
Also available as eBook
0,00 € free of charge
Available
Add to shopping cart
Add to notepad
 Further options for registered users

englischDisease Interception is based on the idea of stopping the development of diseases before the clinical manifestation by providing a targeted (medical) intervention. The concept is located between the categories of prevention and treatment of illness and addresses a new group of people: those who are no longer completely healthy, but who are not yet ill in the traditional sense implying a lack of symptoms or functional impairment. The articles focus on the framework needed for the development and application of Disease Interception, in particular the use of health data and digitalization, but also on the patients' perspective, the ethical implications, and the law of statutory health insurance.

 

With contributions by

Dr. Léon Beyer | Dr. Sarah Diner | Dr. Martin Danner | Dr. Anke Diehl, M.A.| Prof. Dr. Klaus Gerwert | Dr. Joschka Haltaufderheide | Prof. Dr. Stefan Huster | Prof. Dr. Thomas Jäschke | Prof. Dr. Alexandra Jorzig | Franz Knieps | Prof. Dr. Robert Ranisch | Dr. Nils Krochmann | Prof. Dr. Frank Stollmann | Prof. Dr. Jochen A. Werner | Lara Wiese | Dr. Silvia Woskowski, LL.M.

Find the cover of the current title in PDF format here: